Analysis of the Positivity Rate of Sector-based Whole-body CT Scans in Grade C Trauma Patients in Essonne
NCT07929168, Not yet recruiting, Centre Hospitalier Sud Francilien
Trial 9
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Analysis of the Positivity Rate of Sector-based Whole-body CT Scans in Grade C Trauma Patients in Essonne | ClinicalTrials.gov |
| NCT number | NCT07929168 | ClinicalTrials.gov |
| Status | Not yet recruiting | ClinicalTrials.gov |
| Enrollment | 100 participants, estimated | ClinicalTrials.gov |
| Lead sponsor | Centre Hospitalier Sud Francilien | ClinicalTrials.gov |
| Conditions | Multiple Trauma/Injuries, Wounds and Injuries | ClinicalTrials.gov |
| Interventions | Whole-body CT scan at the sector hospital | ClinicalTrials.gov |
| First posted | 2026-11-10 | ClinicalTrials.gov |
| Last updated | 2026-11-10 | ClinicalTrials.gov |
Registered outcomes 4
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Proportion of pathological whole-body CT scans | at day 0 | A whole-body CT scan is considered pathological if it shows trauma-related lesions on imaging, whatever their severity. Lesions discovered incidentally or present before the accident are not counted. Data are collected from the Essonne SAMU dispatch software and, for missing data, by calling the receiving emergency departments of the sector hospitals. | ClinicalTrials.gov |
| Secondary | Rate of secondary transfers to a trauma center | at day 0 | Final orientation of patients with a pathological whole-body CT scan, analysed qualitatively: proportion of patients secondarily transferred to a level 1 trauma center or an intensive care unit, and distribution between patients who can be managed at the sector hospital and those requiring care in a level 1 or level 2 trauma center. | ClinicalTrials.gov |
| Secondary | Total time from initial SMUR care to arrival at the final destination | at day 0 | Total duration between the initial SMUR care and the arrival of the patient at the final destination, used to evaluate the impact of under-triage of grade C trauma patients by comparison of delays (Wilcoxon test). Delays are described as medians with interquartile ranges. | ClinicalTrials.gov |
| Secondary | Proportion of pathological whole-body CT scans according to the collected variables | at day 0 | Descriptive analysis of the cohort of grade C trauma patients: proportion of pathological scans according to age, sex, medical background, type of accident and the criterion defining grade C. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)